newsfilter
← Latest News
GlobeNewswire·

Ambrx Expands Leadership Team with Appointment of Andrew Aromando as Chief Operating Officer

SAN DIEGO, May 04, 2023 (GLOBE NEWSWIRE) -- Ambrx Biopharma Inc., or Ambrx (NASDAQ:AMAM), today announced the appointment of Andrew P. Aromando as Chief Operating Officer. Mr. Aromando brings over 30 years of